Labcorp Pre-Tax Profit Margin 2010-2023 | LH
Current and historical pre-tax profit margin for Labcorp (LH) from 2010 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Labcorp pre-tax profit margin for the three months ending December 31, 2023 was .
| Labcorp Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| 2023-12-31 |
$12.16B |
$0.57B |
4.68% |
| 2023-09-30 |
$12.04B |
$0.64B |
5.35% |
| 2023-06-30 |
$11.85B |
$0.72B |
6.08% |
| 2023-03-31 |
$11.74B |
$0.88B |
7.46% |
| 2022-12-31 |
$11.87B |
$1.24B |
10.43% |
| 2022-09-30 |
$10.76B |
$1.76B |
16.38% |
| 2022-06-30 |
$11.96B |
$2.22B |
18.52% |
| 2022-03-31 |
$12.88B |
$2.51B |
19.46% |
| 2021-12-31 |
$13.14B |
$2.89B |
21.98% |
| 2021-09-30 |
$16.56B |
$3.68B |
22.25% |
| 2021-06-30 |
$16.39B |
$3.86B |
23.57% |
| 2021-03-31 |
$15.32B |
$3.51B |
22.91% |
| 2020-12-31 |
$13.98B |
$2.22B |
15.87% |
| 2020-09-30 |
$12.44B |
$1.27B |
10.20% |
| 2020-06-30 |
$11.48B |
$0.61B |
5.31% |
| 2020-03-31 |
$11.59B |
$0.58B |
5.02% |
| 2019-12-31 |
$11.56B |
$1.11B |
9.56% |
| 2019-09-30 |
$11.39B |
$1.03B |
9.02% |
| 2019-06-30 |
$11.29B |
$1.24B |
10.98% |
| 2019-03-31 |
$11.28B |
$1.28B |
11.38% |
| 2018-12-31 |
$11.33B |
$1.27B |
11.21% |
| 2018-09-30 |
$11.29B |
$1.32B |
11.70% |
| 2018-06-30 |
$11.08B |
$1.09B |
9.82% |
| 2018-03-31 |
$10.74B |
$1.05B |
9.81% |
| 2017-12-31 |
$10.31B |
$1.08B |
10.45% |
| 2017-09-30 |
$9.90B |
$1.06B |
10.66% |
| 2017-06-30 |
$9.70B |
$1.05B |
10.85% |
| 2017-03-31 |
$9.60B |
$1.09B |
11.30% |
| 2016-12-31 |
$9.55B |
$1.07B |
11.24% |
| 2016-09-30 |
$9.52B |
$1.01B |
10.56% |
| 2016-06-30 |
$9.42B |
$0.99B |
10.56% |
| 2016-03-31 |
$9.26B |
$0.95B |
10.24% |
| 2015-12-31 |
$8.68B |
$0.73B |
8.38% |
| 2015-09-30 |
$7.89B |
$0.73B |
9.28% |
| 2015-06-30 |
$7.13B |
$0.70B |
9.81% |
| 2015-03-31 |
$6.37B |
$0.67B |
10.45% |
| 2014-12-31 |
$6.01B |
$0.82B |
13.66% |
| 2014-09-30 |
$5.94B |
$0.83B |
14.05% |
| 2014-06-30 |
$5.85B |
$0.85B |
14.45% |
| 2014-03-31 |
$5.80B |
$0.86B |
14.87% |
| 2013-12-31 |
$5.81B |
$0.92B |
15.75% |
| 2013-09-30 |
$5.78B |
$0.91B |
15.81% |
| 2013-06-30 |
$5.73B |
$0.91B |
15.87% |
| 2013-03-31 |
$5.69B |
$0.92B |
16.10% |
| 2012-12-31 |
$5.67B |
$0.95B |
16.67% |
| 2012-09-30 |
$5.63B |
$0.98B |
17.37% |
| 2012-06-30 |
$5.62B |
$0.97B |
17.29% |
| 2012-03-31 |
$5.60B |
$0.92B |
16.47% |
| 2011-12-31 |
$5.54B |
$0.87B |
15.63% |
| 2011-09-30 |
$5.47B |
$0.86B |
15.66% |
| 2011-06-30 |
$5.34B |
$0.85B |
15.98% |
| 2011-03-31 |
$5.18B |
$0.91B |
17.52% |
| 2010-12-31 |
$5.00B |
$0.92B |
18.31% |
| 2010-09-30 |
$4.87B |
$0.90B |
18.53% |
| 2010-06-30 |
$4.78B |
$0.91B |
19.01% |
| 2010-03-31 |
$4.73B |
$0.88B |
18.61% |
| 2009-12-31 |
$4.70B |
$0.88B |
18.83% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$17.493B |
$12.162B |
|
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
|
